AQUAMEPHYTON Side Effects

5467992-3 | Bradycardia, Burning Sensation, Cyanosis, Flushing, Hyperhidrosis, Infusion Site Warmth
on Sep 25, 2007 Female patient from UNITED STATES , 49 years of age, was diagnosed with international normalised ratio increased and was treated with Aquamephyton (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, burning sensation, cyanosis, flushing, hyperhidrosis, infusion site warmth. Aquamephyton dosage: 10mg 1mg Gram Now Ivss.

5456453-3 | Chest Discomfort, Dyspnoea, Face Oedema, Hyperhidrosis, Hypotension, Prothrombin Time Prolonged, Tachycardia, Visual Disturbance, Vomiting
Patient was taking Aquamephyton (View Usage). Patient had the following side effects: chest discomfort, dyspnoea, face oedema, hyperhidrosis, hypotension, prothrombin time prolonged, tachycardia, visual disturbance, vomiting on Sep 14, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 98.33 lb, was diagnosed with prothrombin time prolonged and. Aquamephyton dosage: 5 Mg X1 Iv Bolus.

5104115-4 | Anaphylactic Reaction, Reversible Ischaemic Neurological Deficit
Adverse event was reported on Sep 07, 2006 by a Male patient taking Aquamephyton (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , child 5 years of age, After Aquamephyton was administered, patient had the following side effects: anaphylactic reaction, reversible ischaemic neurological deficit. Patient was hospitalized.

5018541-5 | Amyloidosis, Cardiac Amyloidosis, Cardiac Failure Congestive, Factor X Deficiency, Prothrombin Time Prolonged, Refusal Of Treatment By Patient, Soft Tissue Haemorrhage, Splenomegaly
on May 26, 2006 Male patient from UNITED STATES , 54 years of age, was diagnosed with haematuria, amyloidosis and was treated with Aquamephyton (View Usage). Patient experienced the following unwanted or unexpected effects: amyloidosis, cardiac amyloidosis, cardiac failure congestive, factor x deficiency, prothrombin time prolonged, refusal of treatment by patient, soft tissue haemorrhage, splenomegaly. Aquamephyton dosage: .


4870105-X | Acute Respiratory Failure
on Dec 29, 2005 Male patient from UNITED STATES , weighting 176.1 lb, was diagnosed with international normalised ratio increased and was treated with Aquamephyton (View Usage). Patient had the following side effects: acute respiratory failure. Aquamephyton dosage: 5mg Once Iv Drip. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PLAVIX (View Plavix Review and Plavix Label ), ISOSORBIDE MN (View Isosorbide Mn Review and Isosorbide Mn Label ), COLACE (View Colace Review and Colace Label ). Patient was hospitalized.

4723565-9 | Cardio-respiratory Arrest
Patient was taking Aquamephyton (View Usage). After Aquamephyton was administered, patient had the following side effects: cardio-respiratory arrest on Jul 20, 2005 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with femoral neck fracture and. Aquamephyton dosage: 1 Mg. Patient was hospitalized.